News & Events
01 2008 Anesiva Announces Expansion of Zingo Agreement in Europe 28 2008 Hyperion Therapeutics Names Bruce F. Scharschmidt CMO 10 2008 - New York Times Takeda Bids for Millennium Pharmaceuticals 07 2008 UPEK Announces Eikon To Go and Demonstrates Fingerprint Authentication Solution with Embedded RSA SecurID® Technology 01 2008 DiObex Announces Presentation of Scientific Poster at Annual Meeting of American Society of Clinical Pharmacology and Therapeutics 25 2008 Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy 24 2008 Trius Raises $30 Million in Series B Financing 18 2008 DiObex and Camurus Sign License Agreement for the Development of DIO-901 in FluidCrystal(R) Extended Release Technology 05 2008 Laszlo Systems Secures $6.6 Million in Additional Funding 04 2008 UPEK® ANNOUNCES SUPPORT FOR RSA SECURID® ONE-TIME PASSWORD TECHNOLOGY 24 2008 Orexigen Therapeutics Announces Pricing of Its Follow-on Offering 21 2007 Anesiva Announces Completion of Common Stock Offering 11 2007 OREXIGEN™ Therapeutics Initiates Fourth Phase III Trial for Contrave™ to Treat Obesity 08 2007 InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer 23 2007 VoluBill Signs Multi-Million Euro Deal for Countrywide Deployment of Charge It with Major Mobile Operator in India 11 2007 Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals 09 2007 CATALYST MOBILE SECURES $10 MILLION IN SERIES B FUNDING 25 2007 Orexigen™ Announces Positive Clinical Results of Its Proprietary Naltrexone Sustained Release Formulation for Use in Contrave™ 24 2007 Laszlo Systems Introduces Enhanced Version of Laszlo Webtop 10 2007 - InfoWorld Introducing the 2007 InfoWorld Bossies -- Laszlo Systems
28 2008 - San Diego Business Journal David Kabakoff Comments on Biotech Investing 21 2008 - Industry Standard Eric Buatois Comments on Silicon Valley VC Confidence Index 09 2008 - New York Times Eric Buatois Comments on Economy 07 2008 Sofinnova Ventures Adds Seasoned Mobile Telecommunications Executive David Hytha 27 2007 Sofinnova Ventures Expands Information Technology Team With Addition of Kauffman Fellow Jay Boddu 30 2007 Sofinnova Ventures Adds Biotechnology Executive Dr. David Kabakoff to the Life Science Team 14 2006 Sofinnova Ventures Closes SVP VII With $375 Million 26 2006 Brian Wilcove Joins Sofinnova Ventures as an Information Technology Venture Partner 02 2005 Jeffrey Stein, Ph.D. Joins Sofinnova Ventures as a Life Science Venture Partner in San Diego 10 2005 Paris-Based Sofinnova Partners Voted European VC Firm of the Year in Global Private Equity Awards
©1997-2007 Sofinnova Ventures, Inc. All rights reserved.
